LUMAL DS tablet, containing Artemether and Lumefantrine, is indicated for the treatment of uncomplicated malaria due to Plasmodium falciparum, contraindicated in patients with a history of hypersensitivity to any component, may cause side effects such as nausea, vomiting, headache, and dizziness, and may interact with drugs that affect liver enzymes, particularly those that induce or inhibit CYP3A4.